1887
Volume 2025, Issue 2
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

Malignant otitis externa (MOE) is an aggressive infection of the external auditory canal and the underlying bony structures of the skull base. Predominantly caused by Pseudomonas, the treatment has shifted from surgical to medical, with antimicrobial therapy being primary, although surgical intervention may still be required. This review aims to provide global prevalence and mortality data on MOE to help institutions establish treatment benchmarks.

A systematic review and meta-analysis followed the Preferred Reporting Items for Systematic Reviews (PRISMA) guidelines. Searches were completed in Scopus and PubMed Databases for articles on MOE mortality published between 1994 and 2022. Publications included data on MOE, mortality, and all genders.

A total of 22 studies involving 9,633 patients diagnosed with MOE were analyzed. The gender distribution was nearly equal, with 4,819 (50.1%) males and 4,814 (49.9%) females. The patients’ ages ranged from 18 to 90 years, with a mean age of 70.3 years. The pooled period prevalence of mortality due to MOE was estimated to be 18% (95% confidence interval: 6–30%), highlighting a significant mortality risk in patients with this condition. Heterogeneity across the studies was high (I2 = 99%, < 0.001). Additionally, the prevalence of comorbidities was significant: 57.1% of patients were diabetic, 51% had hypertension, and other notable comorbidities included chronic pulmonary diseases (12.2%), liver disease (7.2%), and malignancies (3.4%). The most common microbiological cause was Pseudomonas aeruginosa (30%), followed by Staphylococcus aureus (10%). Surgical interventions were performed in 3.7% of cases, and cranial nerve involvement was reported in 9% of patients, primarily affecting the facial nerve (91%). Morbidity related to MOE was found to be 15.2%, and sepsis was a complication in 0.5% of cases. The results underscore the importance of addressing both comorbidities and mortality risks in managing MOE patients.

This review highlights a significant global mortality rate of 18% in patients with MOE, with comorbidities like diabetes and hypertension contributing to worse outcomes. Despite current treatment advancements, mortality and morbidity remain substantial, stressing the need for early diagnosis, targeted interventions, and improved management strategies to enhance patient survival and outcomes.

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2025.53
2025-06-09
2025-07-17
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2025/2/qmj.2025.53.html?itemId=/content/journals/10.5339/qmj.2025.53&mimeType=html&fmt=ahah

References

  1. Honnurappa V, Ramdass S, Mahajan N, Vijayendra VK, Redleaf M. Effective inexpensive management of necrotizing otitis externa is possible in resource-poor settings. Ann Otol Rhinol Laryngol. 2019; 128:(9)848–54. https://doi.org/10.1177/0003489419846143
    [Google Scholar]
  2. Peled C, Parra A, El-Saied S, Kraus M, Kaplan DM. Surgery for necrotizing otitis externa-indications and surgical findings. Eur Arch Otorhinolaryngol. 2020; 277:(5)1327–34. https://doi.org/10.1007/s00405-020-05842-x
    [Google Scholar]
  3. Tsilivigkos C, Avramidis K, Ferekidis E, Doupis J. Malignant external otitis: what the diabetes specialist should know-a narrative review. Diabetes Ther. 2023; 14:(4)629–38. https://doi.org/10.1007/s13300-023-01390-9
    [Google Scholar]
  4. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010; 8:(5)336–41. https://doi.org/10.1016/j.ijsu.2010.02.007
    [Google Scholar]
  5. Hoy D, Brooks P, Woolf A, Blyth F, March L, Bain C, et al.. Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement. J Clin Epidemiol. 2012; 65:(9)934–9. https://doi.org/10.1016/j.jclinepi.2011.11.014
    [Google Scholar]
  6. Pichon M, Joly V, Argy N, Houze S, Bretagne S, Alanio A, et al.. Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review. Infection. 2020; 48:(2)193–203. https://doi.org/10.1007/s15010-020-01394-8
    [Google Scholar]
  7. Hatch JL, Bauschard MJ, Nguyen SA, Lambert PR, Meyer TA, McRackan TR. Malignant otitis externa outcomes: a study of the university healthsystem consortium database. Ann Otol Rhinol Laryngol. 2018; 127:(8)514–20. https://doi.org/10.1177/0003489418778056
    [Google Scholar]
  8. Sylvester MJ, Sanghvi S, Patel VM, Eloy JA, Ying YM. Malignant otitis externa hospitalizations: analysis of patient characteristics. Laryngoscope. 2017; 127:(10)2328–36. https://doi.org/10.1002/lary.26401
    [Google Scholar]
  9. Stern Shavit S, Soudry E, Hamzany Y, Nageris B. Malignant external otitis: factors predicting patient outcomes. Am J Otolaryngol. 2016; 37:(5)425–30. https://doi.org/10.1016/j.amjoto.2016.04.005
    [Google Scholar]
  10. Baig R, Khan QA, Sadiq MA, Awan S, Ahmad K. A case of orbital apex syndrome in a patient with malignant otitis externa. J Pak Med Assoc. 2013; 63:(2)271–3. https://doi.org/10.1016/j.amjoto.2016.04.00
    [Google Scholar]
  11. Loh S, Loh WS. Malignant otitis externa: an Asian perspective on treatment outcomes and prognostic factors. Otolaryngol Head Neck Surg. 2013; 148:(6)991–6. https://doi.org/10.1177/0194599813482107
    [Google Scholar]
  12. Soudry E, Hamzany Y, Preis M, Joshua B, Hadar T, Nageris BI. Malignant external otitis: analysis of severe cases. Otolaryngol Head Neck Surg. 2011; 144:(5)758–62. https://doi.org/10.1177/0194599810396132
    [Google Scholar]
  13. Joshua BZ, Sulkes J, Raveh E, Bishara J, Nageris BI. Predicting outcome of malignant external otitis. Otol Neurotol. 2008; 29:(3)339–43. https://doi.org/10.1097/MAO.0b013e3181661879
    [Google Scholar]
  14. Soudry E, Joshua BZ, Sulkes J, Nageris BI. Characteristics and prognosis of malignant external otitis with facial paralysis. Arch Otolaryngol Head Neck Surg. 2007; 133:(10)1002–4. https://doi.org/10.1001/archotol.133.10.1002
    [Google Scholar]
  15. Mani N, Sudhoff H, Rajagopal S, Moffat D, Axon PR. Cranial nerve involvement in malignant external otitis: implications for clinical outcome. Laryngoscope. 2007; 117:(5)907–10. https://doi.org/10.1097/MLG.0b013e318039b30f
    [Google Scholar]
  16. Agada FO, Sharma R, Makura ZG. Atypical presentation of cutaneous tuberculosis and a retropharyngeal neck abscess. Ear Nose Throat J. 2006; 85:(1)60–2. https://doi.org/10.1097/MLG.0b013e318039b30
    [Google Scholar]
  17. Singh A, Al Khabori M, Hyder MJ. Skull base osteomyelitis: diagnostic and therapeutic challenges in atypical presentation. Otolaryngol Head Neck Surg. 2005; 133:(1)121–5. https://doi.org/10.1016/j.otohns.2005.03.024
    [Google Scholar]
  18. Lancaster J, Alderson DJ, McCormick M. Non-pseudomonal malignant otitis externa and jugular foramen syndrome secondary to cyclosporin-induced hypertrichosis in a diabetic renal transplant patient. J Laryngol Otol. 2000; 114:(5)366–9. https://doi.org/10.1258/0022215001905580
    [Google Scholar]
  19. Harley WB, Dummer JS, Anderson TL, Goodman S. Malignant external otitis due to Aspergillus flavus with fulminant dissemination to the lungs. Clin Infect Dis. 1995; 20:(4)1052–4. https://doi.org/10.1093/clinids/20.4.1052
    [Google Scholar]
  20. Krishnamoorthy M, Othman NAN, Hassan NEB, Hitam SB. Candida skull base osteomyelitis: a case report and literature review. Acta Medica (Hradec Kralove). 2020; 63:(2)82–5. https://doi.org/10.14712/18059694.2020.22
    [Google Scholar]
  21. Bhasker D, Hartley A, Agada F. Is malignant otitis externa on the increase? A retrospective review of cases. Ear Nose Throat. J. 2017; 96:(2)E1–E5. https://doi.org/10.1177/014556131709600211
    [Google Scholar]
  22. Auinger AB, Dahm V, Stanisz I, Schwarz-Nemec U, Arnoldner C. The challenging diagnosis and follow-up of skull base osteomyelitis in clinical practice. Eur Arch Otorhinolaryngol. 2021; 278:(12)4681–8. https://doi.org/10.1007/s00405-020-06576-6
    [Google Scholar]
  23. Chen CN, Chen YS, Yeh TH, Hsu CJ, Tseng FY. Outcomes of malignant external otitis: survival vs mortality. Acta Otolaryngol. 2010; 130:(1)89–94. https://doi.org/10.3109/00016480902971247
    [Google Scholar]
  24. Glikson E, Sagiv D, Wolf M, Shapira Y. Necrotizing otitis externa: diagnosis, treatment, and outcome in a case series. Diagn Microbiol Infect Dis. 2017; 87:(1)74–8. https://doi.org/10.1016/j.diagmicrobio.2016.10.017
    [Google Scholar]
  25. Ridder GJ, Breunig C, Kaminsky J, Pfeiffer J. Central skull base osteomyelitis: new insights and implications for diagnosis and treatment. Eur Arch Otorhinolaryngol. 2015; 272:(5)1269–76. https://doi.org/10.1007/s00405-014-3390-y
    [Google Scholar]
  26. Sekar R, Raja K, Ganesan S, Alexander A, Saxena SK. Clinical and current microbiological profile with changing antibiotic sensitivity in malignant otitis externa. Indian J Otolaryngol Head Neck Surg. 2022; 74:(Suppl 3)4422–7. https://doi.org/10.1007/s12070-021-03068-9
    [Google Scholar]
  27. Gonzalez J, Suarez L, de Leon J. Malignant otitis externa: an updated review. Am J Otolaryngol–Head Neck Med Surg. 2021; 42:102894. https://doi.org/10.1016/j.amjoto.2020.102894
    [Google Scholar]
  28. Treviño González JL, Reyes Suárez LL, Hernández de León JE. Malignant otitis externa: an updated review. Am J Otolaryngol. 2021; 42:(2)102894. https://doi.org/10.1016/j.amjoto.2020.102894
    [Google Scholar]
/content/journals/10.5339/qmj.2025.53
Loading
/content/journals/10.5339/qmj.2025.53
Loading

Data & Media loading...

  • Article Type: Review Article
Keyword(s): externaMalignantmortality and otitis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error